IOCB Tech operates as a technology transfer and commercialization company focused on transforming research outputs into market-ready products through structured intellectual property and partnering processes. Core activities include identification of commercially attractive research projects, evaluation of market potential and patentability, IP protection and portfolio management, project development support via project management, and negotiation of licensing and partnership agreements with industrial and pharmaceutical partners. The business portfolio is concentrated on inventions from medicinal chemistry, life sciences and material sciences, with principal application areas spanning new therapeutics, diagnostics and research tools. Geographic reach is international through licensing and partnering with global industry participants. Key assets include the IP portfolio, commercialization expertise and connectivity to the research base generating proprietary inventions. Strategic positioning is that of a specialized commercialization platform bridging academic research and industrial product development, with a focus on accelerating value creation through licensing, co-development and strategic partnerships.
Headquarters
Flemingovo namesti 542/2
Prague; The City of Prague;
Postal Code: 16000
Contact Details: Purchase the Iocb Tech S.R.O. report to view the information.
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service